Skip to main content
editorial
. 2022 Nov;10(21):1184. doi: 10.21037/atm-22-4581

Table 1. Cmax, AUC and T1/2 for Irinotecan, sacituzumab Govitecan and trastuzumab deruxtecan.

Drug Cmax (ng/mL) AUC (ng*h/mL) T½ (hours)
Irinotecan 350 mg i.v. (10) 56 451 13.8
Sacituzumab Govitecan (11) 90 2,730 19.7
Trastuzumab deruxtecan (12-14) 1 NA 168

AUC, area under the curve; NA, not available.